B-cell lymphomas develop when B-cells mutate and grow abnormally. These cancers can form solid tumors or circulate in the blood and lymphatic system. The most affected areas are lymph nodes in the neck, underarms, or groin but they can also appear in the chest, abdomen, or skin.
There are many subtypes of B-cell lymphoma, ranging from slow-growing (indolent) to aggressive. Treatment depends heavily on the specific subtype, stage, and overall health of the patient.
Here are the most well-known subtypes:
Diffuse Large B-Cell Lymphoma (DLBCL): The most common and aggressive form. It can appear suddenly and spread quickly, often requiring urgent treatment. Symptoms may include rapidly enlarging lymph nodes, fever, weight loss, and night sweats.
Follicular Lymphoma: A slow-growing, chronic form that may not need treatment right away. Patients may live many years with follicular lymphoma while managing flare-ups or progression.
Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma (CLL/SLL): A slow-growing cancer that primarily affects older adults. CLL involves the blood and bone marrow, while SLL mainly affects the lymph nodes. They are considered the same disease in different locations.
B-cell lymphoma symptoms vary by type and location, but may include:
In people with darker skin, swelling or masses may appear less visibly red and could be mistaken for other conditions.
While the exact cause is unknown, B-cell lymphoma begins with genetic mutations that make B-cells grow uncontrollably. These mutations may be triggered by:
Diagnosing B-cell lymphoma involves several steps to confirm the type and extent of the disease:
Accurate diagnosis requires reviewing both the cell appearance under a microscope and specific genetic markers.
Treatment is based on the lymphoma type, growth rate, stage, and overall health of the patient.
Chemotherapy: Often combined with other drugs. R-CHOP is a standard treatment for aggressive B-cell lymphoma like DLBCL.
Immunotherapy: Monoclonal antibodies (e.g., rituximab) help target and destroy B-cells.
Radiation therapy: Used for localized lymphoma or to shrink large tumors.
Targeted therapy: Drugs that block specific cancer pathways, such as BTK inhibitors for CLL.
Stem cell transplantation: For patients with relapsed or high-risk lymphoma.
Watchful waiting: May be recommended for slow-growing lymphomas that don’t yet require treatment.
With advances in treatment, many people live full lives after diagnosis—especially with early detection and personalized care. Ongoing support and monitoring help manage side effects and prevent recurrence.
Patients are encouraged to:
